Voyager Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction THRY Q1 2026 Earnings Significant EPS Beat Surprises Market Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges CLPT Q1 2026 Earnings EPS Misses Estimates Stock Slips 222 GLAD Q1 2026 Earnings EPS Misses Estimates Shares Rise Despite 2057 Surprise IPAR Q1 2026 Earnings EPS Surpasses Estimates by 10 Signaling Strong Operational Performance